Yep, turn the screws on this recalcitrant hand picked too busy Board and distracted management on other interests prone to gild the Lilly as we've seen time and again to our detriment.
Expect no announcement of anything new or substantive for at least 2 years. Then likely another CR (SPP and Dr. M allotment). Not to mention more free options with unbelievable voting support. No credible US outfit would partner with this inept flock don't you think. Pity we're heading it seems to oblivion as the IP in both products could have been commercialised if we'd had even 10% of the competence evidence suggests we have. One thing can look forward to ....tax losses sadly it seems.
ALT Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
